Literature DB >> 18079281

Prebiotic oligosaccharides and the enterohepatic circulation of bile salts in rats.

Hester van Meer1, Gunther Boehm, Frans Stellaard, Aldwin Vriesema, Jan Knol, Rick Havinga, Pieter J Sauer, Henkjan J Verkade.   

Abstract

Human milk contains prebiotic oligosaccharides, which stimulate the growth of intestinal bifidobacteria and lactobacilli. It is unclear whether the prebiotic capacity of human milk contributes to the larger bile salt pool size and the more efficient fat absorption in infants fed human milk compared with formula. We determined the effect of prebiotic oligosaccharides on bile salt metabolism in rats. Rats were fed a control diet or an isocaloric diet containing a mixture of galactooligosaccharides (GOS), long-chain fructooligosaccharides (lcFOS), and acidified oligosaccharides (AOS) for 3 wk. We determined synthesis rate, pool size, and fractional turnover rate (FTR) of the primary bile salt cholate by using stable isotope dilution methodology. We quantified bile flow and biliary bile salt secretion rates through bile cannulation. Prebiotic intervention resulted in significant changes in fecal and colonic flora: the proportion of lactobacilli increased 344% (P < 0.01) in colon content and 139% (P < 0.01) in feces compared with the control group. The number of bifidobacteria also increased 366% (P < 0.01) in colon content and 282% in feces after the prebiotic treatment. Furthermore, pH in both colon and feces decreased significantly with 1.0 and 0.5 pH point, respectively. However, despite this alteration of intestinal bacterial flora, no significant effect on relevant parameters of bile salt metabolism and cholate kinetics was found. The present data in rats do not support the hypothesis that prebiotics naturally present in human milk contribute to a larger bile salt pool size or altered bile salt pool kinetics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18079281     DOI: 10.1152/ajpgi.00396.2007

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  10 in total

1.  Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids.

Authors:  Aafke W F Janssen; Tom Houben; Saeed Katiraei; Wieneke Dijk; Lily Boutens; Nieke van der Bolt; Zeneng Wang; J Mark Brown; Stanley L Hazen; Stéphane Mandard; Ronit Shiri-Sverdlov; Folkert Kuipers; Ko Willems van Dijk; Jacques Vervoort; Rinke Stienstra; Guido J E J Hooiveld; Sander Kersten
Journal:  J Lipid Res       Date:  2017-05-22       Impact factor: 5.922

2.  Hepatic overexpression of Abcb11 in mice promotes the conservation of bile acids within the enterohepatic circulation.

Authors:  Anne S Henkel; Karin E R Gooijert; Rick Havinga; Renze Boverhof; Richard M Green; Henkjan J Verkade
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-08       Impact factor: 4.052

3.  Development of the Digestive System-Experimental Challenges and Approaches of Infant Lipid Digestion.

Authors:  Evan Abrahamse; Mans Minekus; George A van Aken; Bert van de Heijning; Jan Knol; Nana Bartke; Raish Oozeer; Eline M van der Beek; Thomas Ludwig
Journal:  Food Dig       Date:  2012-11-07

4.  Male apoE*3-Leiden.CETP mice on high-fat high-cholesterol diet exhibit a biphasic dyslipidemic response, mimicking the changes in plasma lipids observed through life in men.

Authors:  Yared Paalvast; Albert Gerding; Yanan Wang; Vincent W Bloks; Theo H van Dijk; Rick Havinga; Ko Willems van Dijk; Patrick C N Rensen; Barbara M Bakker; Jan Albert Kuivenhoven; Albert K Groen
Journal:  Physiol Rep       Date:  2017-10-16

5.  Fecal Bile Salts and the Development of Necrotizing Enterocolitis in Preterm Infants.

Authors:  Christian V Hulzebos; Anne G J F van Zoonen; Jan B F Hulscher; Trijntje E Schat; Elisabeth M W Kooi; Martijn Koehorst; Renze Boverhof; Paul F M Krabbe; Albert K Groen; Henkjan J Verkade
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

6.  Dietary Mannan Oligosaccharides Modulate Gut Microbiota, Increase Fecal Bile Acid Excretion, and Decrease Plasma Cholesterol and Atherosclerosis Development.

Authors:  Lisa R Hoving; Saeed Katiraei; Marieke Heijink; Amanda Pronk; Lianne van der Wee-Pals; Trea Streefland; Martin Giera; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  Mol Nutr Food Res       Date:  2018-05       Impact factor: 5.914

Review 7.  The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement.

Authors:  Yun Ji; Yue Yin; Lijun Sun; Weizhen Zhang
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

8.  The effect of dietary prebiotics and probiotics on body weight, large intestine indices, and fecal bile acid profile in wild type and IL10-/- mice.

Authors:  Shiu-Ming Kuo; Patricia M Merhige; Lee R Hagey
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

9.  Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.

Authors:  Mark M Smits; Lennart Tonneijck; Marcel H A Muskiet; Trynke Hoekstra; Mark H H Kramer; Michaela Diamant; Max Nieuwdorp; Albert K Groen; Djuna L Cahen; Daniël H van Raalte
Journal:  Diabetes Obes Metab       Date:  2016-08-30       Impact factor: 6.577

10.  Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.

Authors:  Anuradha Rao; Ivo P van de Peppel; Sanjeev Gumber; Saul J Karpen; Paul A Dawson
Journal:  Front Med (Lausanne)       Date:  2020-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.